Biotest
Daniela Zipp has extensive work experience in the pharmaceutical industry. Daniela began their career at ICON plc in 2001, where they worked as a Senior Project Manager for 10 years. In 2011, they joined Biotest AG as a Senior Manager in Operations Corporate Clinical Research, and later moved into roles such as Associate Director and Senior Director of Clinical Operations. Daniela is currently the Head of Operations & Clinical Systems CCR&D at Biotest AG.
Daniela Zipp completed their education at Goethe University Frankfurt, where they obtained a Diploma in Biology.
This person is not in any offices
Biotest
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.